2021-09-21-埃森哲-Technology_Vision_2021_for_Life_Sciences_21页_4mb

Technology Vision 2021 for Life Sciences Summary

Core Content

The Technology Vision 2021 for Life Sciences outlines the evolving landscape of the industry, emphasizing the need for innovative and strategic leadership to navigate rapid technological change. It highlights the importance of digital-first approaches, collaborative ecosystems, and human-centric technology integration to meet the demands of a new era in healthcare.

The report presents five key technology trends that are shaping the future of life sciences companies:

1. Stack Strategically – Aligning internal technology stacks with business goals to create flexible, adaptive ecosystems.
2. Mirrored World – Leveraging digital twins to simulate and optimize complex processes across the entire value chain.
3. I, Technologist – Democratizing technology to make it accessible and usable across all functions, fostering a culture of digital fluency.
4. Anywhere, Everywhere – Embracing hybrid and remote work models with a focus on trust, security, and seamless collaboration.
5. From Me to We – Shifting from internal development to strategic partnerships to accelerate innovation and adaptability.

Main Viewpoints

• Leadership and Innovation: The industry is moving toward bold, innovative leadership that prioritizes technology. Leaders are actively building the "new normal" rather than waiting for it.
• Digital Transformation: The pandemic has accelerated the adoption of digital technologies, pushing companies to rethink their operations and workflows.
• Ecosystem Collaboration: The success of the industry now depends on forming strong, trust-based partnerships across the ecosystem, including with startups and other stakeholders.
• Technology Democratization: Making technology accessible to all employees, especially through low-code platforms and other user-friendly tools, is essential for fostering innovation and digital fluency.
• Resilience and Adaptability: Companies must build resilient and adaptable systems to respond to market disruptions and evolving patient needs.

Key Information

• 96% of biopharma executives believe capturing tomorrow's market will require defining it, emphasizing the need for proactive innovation.
• 97% of biopharma executives report their organization is operating with a renewed sense of purpose.
• 94% of biopharma executives believe their business and technology strategies are becoming inseparable.
• 98% of biopharma executives believe technology democratization is becoming critical for innovation.
• 92% of biopharma executives believe the remote workforce opens up access to difficult-to-find talent.
• 98% of biopharma executives believe multiparty systems will enable more resilient and adaptable partnerships.

Technology Trends

1. Stack Strategically

• Companies must align their internal technology architecture with business strategies to create competitive advantage.
• Cloud and microservices are key to building a future-ready, decoupled architecture.
• A product-centric approach is replacing the traditional project-based model, enabling faster delivery and better integration.

2. Mirrored World

• Digital twins are being used to simulate and optimize entire systems, from factories to supply chains.
• These models allow for risk-free experimentation and faster decision-making.
• The use of digital twins in vaccine development and medical device testing has shown significant value.

3. I, Technologist

• Democratizing technology is essential to empower all employees to think and act like technologists.
• Training programs are needed to upskill the workforce and build digital fluency.
• A culture of cooperation, agility, and innovation is required to support this transformation.

4. Anywhere, Everywhere

• Hybrid and remote work models are becoming the norm, requiring new governance and trust-based frameworks.
• Companies must balance flexibility with security and compliance.
• Function-based task allocation is more effective than role-based, enabling better remote work integration.

5. From Me to We

• Partnerships are becoming the primary method for innovation, with M&A and collaboration being key strategies.
• Multiparty systems are critical for enabling data sharing and algorithmic collaboration while maintaining security and trust.
• The focus is shifting from internal development to external collaboration, driven by the need for speed and agility.

Survey Insights

• A global survey of 100 biopharma executives was conducted by Accenture to capture insights into technology adoption and investment.
• The survey highlighted the increasing importance of cloud, microservices, and digital twins in driving innovation and operational efficiency.
• The report stresses the need for sustainable, future-ready operations that integrate technology at every level of the organization.

Conclusion

The life sciences industry is at a pivotal moment, requiring leaders to embrace digital-first strategies, ecosystem thinking, and human-centric innovation. By aligning technology with business goals, fostering digital fluency, and building trust-based partnerships, companies can create a more resilient and adaptable future. The report encourages action through specific recommendations for each trend, emphasizing the need for strategic investment, cultural transformation, and ecosystem collaboration.

Authors and Contributors

• Shalu Chadha – Life Sciences Technology Lead
• Geoff Schmidt – Life Sciences Cloud First Lead
• Tim Durst – Life Sciences Medical Technology Lead
• David Hole – Life Sciences Talent and Organization Lead
• Anne Marie O'Halloran – Life Sciences Supply Chain and Industry X Lead
• Frances Taheri – Accenture Ventures Digital Health Lead
• Stuart Henderson – Global Life Sciences Lead
• Brad Michel – North America Life Sciences Lead
• Petra Jantzer – EU Life Sciences Lead
• Aman Bajaaj – Growth Markets Life Sciences Lead
• Ken Munie – Accenture Strategy Life Sciences Lead
• Andy Greenberg – North America Digital Health Lead

Resources

• New Science: A new economic reality for innovation and growth
• Transforming from a project to product-centric organization
• Biopharma on AWS: Bring advanced and differentiated therapeutics to market faster with AWS
• Could digital twins revolutionise healthcare?
• How Pfizer Makes Its Covid-19 Vaccine
• Technology Vision 2021 Business and IT Biopharma Executive Survey
• TripleBlind: Unlock Private Data Sharing

About Accenture

Accenture is a global professional services company with expertise in digital, cloud, and security. It serves clients across more than 40 industries, including life sciences, with a focus on Strategy and Consulting, Interactive, Technology, and Operations. The company employs 569,000 people in over 120 countries, delivering on the promise of technology and human ingenuity.

About Accenture Life Sciences

Accenture's Life Sciences group helps clients transform how medical treatments are discovered, developed, and delivered. It offers end-to-end services in strategy, consulting, digital/analytics, technology, and operations, with a strong emphasis on R&D, Sales & Marketing, Patient Services, and Supply Chain.

The group connects more than 20,000 skilled professionals across over 50 countries, all committed to helping clients achieve their business objectives and deliver better health and economic outcomes.